1 Oct 2018 - The Global Single Cell Analysis Market was valued at USD 1,183.7 million in 2015. The heavy investments and funding by the government in R&D in the field of medical diagnostics and adoption of single cell analysis devices for the diagnosis of infectious diseases is driving the industry growth. The availability of such technically advanced products influences the market movement and product penetration.
The prevalence of life threatening diseases such as cancer, immunological and neurological diseases is rising recently and the single cell analysis is able to understand the diseases complexity and its association with cellular heterogeneity. Thus, it drives the demand for single cell analysis as a diagnostic tool.
The adoption of single cell analytical techniques is growing over in past few years due to the acceptance of stem cell therapy in in-vitro fertilization (IVF) and non-invasive prenatal diagnosis. In contrast, the high cost of devices and one-time investment in purchase due to the longer shelf life hold back the industry growth.
Segment Insights
Based on the commercial availability the market is segmented into consumables products and instruments. The instruments are subdivided into the manual and automated segments. The consumables segment holds the maximum market shares in 2016 due to its continuous demand and repeatable purchases.
The genetic and stem cell technology augmented the growth of the industry. The wide acceptance of next-generation sequencing (NGS) technology is fuelling the growth of the business. The long term contracts with the potential customer’s result into the market sustainability for the manufacturers. The accurate and efficient product performance and easy procedures with accurate results generate the demand for advanced assay kits.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/single-cell-analysis-market/request-sample
Therefore, the consumables segment expected to hold the largest market share in 2016 and is anticipated to grow at the fastest rate during the forecast period.
The longer shelf life of these instruments discontinued the repeat purchase of these products. Therefore, this can restrain the industry growth but at the same time technology advancement supports the market growth and expected to grow at significant rate during the forecast period.
Regional Insights
North America dominant the single cell analysis market followed by the Europe in 2016. The North America hold the total 37.18% market shares in 2016.The significant industry growth in this region is owing to a large number of biotechnology and biopharmaceutical company in this region. The high approval of gene based technologies by these companies and other research laboratories boosts the market growth for genomics segment.
In addition to that, the various government initiatives such as funding for various research projects and R&D activities in the field for diseases diagnosis encourages the market development. The U.S government Cell Analysis Program by the National Institute of Health, U.S. (NIH) is working in the single cell analysis by proposing the solutions in technical difficulties and try its compliance. As a result, the adoption rate increases for instruments. The program also leads the various meetings, conferences and launch the new products for the better promotion and to spread product information among the customer. Therefore, North America dominated the global marketplace.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/single-cell-analysis-market
Asia Pacific is anticipated to grow at the fastest rate with CAGR of over 20.3% during the forecast period. The rising healthcare expenditure, availability of skilled worker for the operation of such instruments and advanced healthcare facilities, such drivers attributes the industry growth in this region. The booming medical tourism and cheap medical treatment fuel the industry growth. The lower cost of healthcare in this region anticipated to speed up the growth rate in this region.
Competitive Insights
The major players in this industry include Merck Millipore GmbH, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Beckman Coulter Inc, Becton, Qiagen N.V, and Dickinson and Company.
Very few players are making this industry very competitive by adopting the strategies such as long-term purchase, bulk purchases on discount offers for the key customer. The mergers and acquisitions help the in the portfolio expansion and broad market capture. On the other hand, the manufacturing cost of such instruments is very high due to quality and accuracy.
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare
The adoption of single cell analytical techniques is growing over in past few years due to the acceptance of stem cell therapy in in-vitro fertilization (IVF) and non-invasive prenatal diagnosis. In contrast, the high cost of devices and one-time investment in purchase due to the longer shelf life hold back the industry growth.
Segment Insights
Based on the commercial availability the market is segmented into consumables products and instruments. The instruments are subdivided into the manual and automated segments. The consumables segment holds the maximum market shares in 2016 due to its continuous demand and repeatable purchases.
The genetic and stem cell technology augmented the growth of the industry. The wide acceptance of next-generation sequencing (NGS) technology is fuelling the growth of the business. The long term contracts with the potential customer’s result into the market sustainability for the manufacturers. The accurate and efficient product performance and easy procedures with accurate results generate the demand for advanced assay kits.
Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/single-cell-analysis-market/request-sample
Therefore, the consumables segment expected to hold the largest market share in 2016 and is anticipated to grow at the fastest rate during the forecast period.
The longer shelf life of these instruments discontinued the repeat purchase of these products. Therefore, this can restrain the industry growth but at the same time technology advancement supports the market growth and expected to grow at significant rate during the forecast period.
Regional Insights
North America dominant the single cell analysis market followed by the Europe in 2016. The North America hold the total 37.18% market shares in 2016.The significant industry growth in this region is owing to a large number of biotechnology and biopharmaceutical company in this region. The high approval of gene based technologies by these companies and other research laboratories boosts the market growth for genomics segment.
In addition to that, the various government initiatives such as funding for various research projects and R&D activities in the field for diseases diagnosis encourages the market development. The U.S government Cell Analysis Program by the National Institute of Health, U.S. (NIH) is working in the single cell analysis by proposing the solutions in technical difficulties and try its compliance. As a result, the adoption rate increases for instruments. The program also leads the various meetings, conferences and launch the new products for the better promotion and to spread product information among the customer. Therefore, North America dominated the global marketplace.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/single-cell-analysis-market
Asia Pacific is anticipated to grow at the fastest rate with CAGR of over 20.3% during the forecast period. The rising healthcare expenditure, availability of skilled worker for the operation of such instruments and advanced healthcare facilities, such drivers attributes the industry growth in this region. The booming medical tourism and cheap medical treatment fuel the industry growth. The lower cost of healthcare in this region anticipated to speed up the growth rate in this region.
Competitive Insights
The major players in this industry include Merck Millipore GmbH, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Beckman Coulter Inc, Becton, Qiagen N.V, and Dickinson and Company.
Very few players are making this industry very competitive by adopting the strategies such as long-term purchase, bulk purchases on discount offers for the key customer. The mergers and acquisitions help the in the portfolio expansion and broad market capture. On the other hand, the manufacturing cost of such instruments is very high due to quality and accuracy.
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare
No comments:
Post a Comment